Potentially inappropriate prescriptions of anticholinergic drugs in patients with benign prostatic hyperplasia.

Luis Fernando Valladales-Restrepo Jorge Enrique Machado-Alba

Published in: The aging male : the official journal of the International Society for the Study of the Aging Male (2019)

A high proportion of patients with benign prostatic hyperplasia were receiving medical management for the relief of symptoms, mostly via monotherapy. However, one-third of patients received some type of medication with anticholinergic properties, being much more frequent after 75 years.

Keyphrases

benign prostatic hyperplasia
lower urinary tract symptoms
end stage renal disease
healthcare
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
clinical trial
patient reported outcomes
physical activity
depressive symptoms
open label
drug induced